Emicerfont

DB12910InvestigationalSmall molecule

Emicerfont has been used in trials studying the diagnostic and treatment of Social Anxiety Disorder and Irritable Bowel Syndrome (IBS).

Mechanism: Pharmacologically active on Corticotropin-releasing hormone receptor 1
Curator reviewed
Formula / weight: C₂₂H₂₄N₆O₂ · 404.474 g/mol (avg)
Code names: GW-876008 · GW-876008X

Resolves to

Compound

Structure

InChIKeyJFHJGXQFESYQGY-UHFFFAOYSA-NSMILESCOC1=CC=C(N2CCC3=C2N=C(C)C=C3N2C=CC(=N2)N2CCNC2=O)C(C)=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Emicerfont, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.